Kerri B Gosselin1, Said Aboud, Christine M McDonald, Sabrina Moyo, Nasim Khavari, Karim Manji, Rodrick Kisenge, Wafaie Fawzi, Mark Kellogg, Hao Q Tran, Gibson Kibiki, Jean Gratz, Jie Liu, Andrew Gewirtz, Eric Houpt, Christopher Duggan. 1. *Division of Pediatric Gastroenterology, UMass Memorial Children's Medical Center, Worcester †Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston MA ‡Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania §Lucile Packard Children's Hospital at Stanford, Palo Alto, CA ||Departments of Nutrition and Global Health and Population, Harvard School of Public Health ¶Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA #Department of Biology, Georgia State University, Atlanta **Kilimanjaro Clinical Research Institute, Moshi, Tanzania ††Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Abstract
OBJECTIVE: Diarrheal diseases are a leading cause of morbidity and mortality worldwide, but the etiology of diarrhea and its relation to nutritional outcomes in resource-limited settings is poorly defined. We sought to determine the etiology of community-acquired diarrhea in Tanzanian infants and to assess the association with anthropometrics and novel intestinal biomarkers. METHODS: A convenience sample of infants in a trial of zinc and/or multivitamin supplementation in Tanzania was selected. Subjects were enrolled at age 6 weeks and studied for 18 months. Stool samples were obtained from children with acute diarrhea. A novel, polymerase chain reaction-based TaqMan array was used to screen stool for 15 enteropathogens. A subset of subjects had serum gastrointestinal biomarkers measured. RESULTS: One hundred twenty-three subjects with diarrhea were enrolled. The mean ± SD age at stool sample collection was 12.4 ± 3.9 months. Thirty-five enteropathogens were identified in 34 (27.6%) subjects: 11 rotavirus, 9 Cryptosporidium spp, 7 Shigella spp, 3 Campylobacter jejuni/coli, 3 heat stable-enterotoxigenic Escherichia coli, and 2 enteropathogenic E coli. Subjects with any identified enteropathogen had significantly lower weight-for-length z scores (-0.55 ± 1.10 vs 0.03 ± 1.30, P = 0.03) at the final clinic visit than those without an identified pathogen. Fifty of the 123 subjects (40.7%) had serum analyzed for antibodies to lipopolysaccharide (LPS) and flagellin. Subjects with any identified enteropathogen had lower immunoglobulin (IgA) antibodies to LPS (0.75 ± 0.27 vs 1.13 ± 0.77, P = 0.01) and flagellin (0.52 ± 0.16 vs 0.73 ± 0.47, P = 0.02) than those without an identified pathogen. CONCLUSIONS: This quantitative polymerase chain reaction method may allow identification of enteropathogens that place children at higher risk for suboptimal growth. IgA anti-LPS and flagellin antibodies hold promise as emerging intestinal biomarkers.
OBJECTIVE:Diarrheal diseases are a leading cause of morbidity and mortality worldwide, but the etiology of diarrhea and its relation to nutritional outcomes in resource-limited settings is poorly defined. We sought to determine the etiology of community-acquired diarrhea in Tanzanian infants and to assess the association with anthropometrics and novel intestinal biomarkers. METHODS: A convenience sample of infants in a trial of zinc and/or multivitamin supplementation in Tanzania was selected. Subjects were enrolled at age 6 weeks and studied for 18 months. Stool samples were obtained from children with acute diarrhea. A novel, polymerase chain reaction-based TaqMan array was used to screen stool for 15 enteropathogens. A subset of subjects had serum gastrointestinal biomarkers measured. RESULTS: One hundred twenty-three subjects with diarrhea were enrolled. The mean ± SD age at stool sample collection was 12.4 ± 3.9 months. Thirty-five enteropathogens were identified in 34 (27.6%) subjects: 11 rotavirus, 9 Cryptosporidium spp, 7 Shigella spp, 3 Campylobacter jejuni/coli, 3 heat stable-enterotoxigenic Escherichia coli, and 2 enteropathogenic E coli. Subjects with any identified enteropathogen had significantly lower weight-for-length z scores (-0.55 ± 1.10 vs 0.03 ± 1.30, P = 0.03) at the final clinic visit than those without an identified pathogen. Fifty of the 123 subjects (40.7%) had serum analyzed for antibodies to lipopolysaccharide (LPS) and flagellin. Subjects with any identified enteropathogen had lower immunoglobulin (IgA) antibodies to LPS (0.75 ± 0.27 vs 1.13 ± 0.77, P = 0.01) and flagellin (0.52 ± 0.16 vs 0.73 ± 0.47, P = 0.02) than those without an identified pathogen. CONCLUSIONS: This quantitative polymerase chain reaction method may allow identification of enteropathogens that place children at higher risk for suboptimal growth. IgA anti-LPS and flagellin antibodies hold promise as emerging intestinal biomarkers.
Authors: Christine M McDonald; Karim P Manji; Rodrick Kisenge; Said Aboud; Donna Spiegelman; Wafaie W Fawzi; Christopher P Duggan Journal: J Nutr Date: 2015-07-22 Impact factor: 4.798
Authors: Sean R Moore; Noélia L Lima; Alberto M Soares; Reinaldo B Oriá; Relana C Pinkerton; Leah J Barrett; Richard L Guerrant; Aldo A M Lima Journal: Gastroenterology Date: 2010-06-02 Impact factor: 22.682
Authors: Karen L Kotloff; James P Nataro; William C Blackwelder; Dilruba Nasrin; Tamer H Farag; Sandra Panchalingam; Yukun Wu; Samba O Sow; Dipika Sur; Robert F Breiman; Abu Sg Faruque; Anita Km Zaidi; Debasish Saha; Pedro L Alonso; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; John B Ochieng; Richard Omore; Joseph O Oundo; Anowar Hossain; Sumon K Das; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Richard A Adegbola; Martin Antonio; M Jahangir Hossain; Adebayo Akinsola; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Kousick Biswas; Ciara E O'Reilly; Eric D Mintz; Lynette Y Berkeley; Khitam Muhsen; Halvor Sommerfelt; Roy M Robins-Browne; Myron M Levine Journal: Lancet Date: 2013-05-14 Impact factor: 79.321
Authors: Pascal Crenn; Pierre De Truchis; Nathalie Neveux; Tatiana Galpérine; Luc Cynober; Jean Claude Melchior Journal: Am J Clin Nutr Date: 2009-07-08 Impact factor: 7.045
Authors: Jie Liu; Furqan Kabir; Jainaba Manneh; Paphavee Lertsethtakarn; Sharmin Begum; Jean Gratz; Steve M Becker; Darwin J Operario; Mami Taniuchi; Lalitha Janaki; James A Platts-Mills; Doris M Haverstick; Mamun Kabir; Shihab U Sobuz; Kaewkanya Nakjarung; Pimmada Sakpaisal; Sasikorn Silapong; Ladaporn Bodhidatta; Shahida Qureshi; Adil Kalam; Queen Saidi; Ndealilia Swai; Buliga Mujaga; Athanasia Maro; Brenda Kwambana; Michel Dione; Martin Antonio; Gibson Kibiki; Carl J Mason; Rashidul Haque; Najeeha Iqbal; Anita K M Zaidi; Eric R Houpt Journal: Lancet Infect Dis Date: 2014-07-09 Impact factor: 25.071
Authors: Sandra Panchalingam; Martin Antonio; Anowar Hossain; Inacio Mandomando; Ben Ochieng; Joseph Oundo; T Ramamurthy; Boubou Tamboura; Anita K M Zaidi; William Petri; Eric Houpt; Patrick Murray; Valeria Prado; Roberto Vidal; Duncan Steele; Nancy Strockbine; Philippe Sansonetti; Roger I Glass; Roy M Robins-Browne; Marija Tauschek; Ann-Marie Svennerholm; Lynette Y Berkeley; Karen Kotloff; Myron M Levine; James P Nataro Journal: Clin Infect Dis Date: 2012-12 Impact factor: 9.079
Authors: Delfina F Hlashwayo; Betuel Sigaúque; Emília V Noormahomed; Sónia M S Afonso; Inácio M Mandomando; Custódio G Bila Journal: PLoS One Date: 2021-01-27 Impact factor: 3.240